학술논문

Delayed Signs of Early Disability Progression After 8.5 Years of Ocrelizumab Treatment in Patients With Relapsing Multiple Sclerosis
Document Type
Journal
Source
NEUROLOGY; APR 25 2023, 100 17, p1929 4p. Supplement: 2
Subject
Language
English
ISSN
1526632X